Isocitrate dehydrogenase gene variants in cancer and their clinical significance
Human isocitrate dehydrogenase (IDH) genes encode for the IDH1, 2 & 3 isoenzymes which catalyse the formation of 2-oxoglutarate from isocitrate and are essential for normal mammalian metabolism. Although mutations in these genes in cancer were long thought to lead to a ‘loss of function’, combin...
Main Authors: | Cadoux-Hudson, T, Schofield, C, McCullagh, JSO |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Portland Press
2021
|
Similar Items
-
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
by: Hvinden, IC, et al.
Published: (2021) -
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
by: Liu, S, et al.
Published: (2021) -
Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
by: Liu, S, et al.
Published: (2020) -
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
by: Shuang Liu, et al.
Published: (2021-11-01) -
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors
by: Reinbold, R, et al.
Published: (2022)